Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
18 Ergebnisse für "engl" unter Roche Glycart AG
Homocysteine enzymatic
... and mortality in patients with coronary artery disease. N Engl J Med 1997;337(4):230-236. Seshadri S ... Engl J Med 2002;346(7):476-483. Stanger O, Fowler B, Piertzik K, et al. Homocysteine, folate and ... coronary artery disease. N Engl J Med 1997;337(4):230-236. Seshadri S, Beiser A, Selhub J, et al. Plasma ... homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346(7):476-483. Stanger O ...
Indicaciones para el tratamiento con warfarina y pruebas de TP/INR
... et al. (1996). N Engl J Med 335, 407-416 Gohlke-Barwolf. (2001) Z Kardiol (german article) 90 Suppl 6 ... [No se ha indicado ningún autor]. (1991) Circulation 84, 527-539 Singer et al. (1990). N Engl J Med ... . (1996). N Engl J Med 335, 407-416 Gohlke-Barwolf. (2001) Z Kardiol (german article) 90 Suppl 6, 112-117 ... /heart-valve-disease [Fecha de acceso: noviembre de 2019] Carabello & Crawford. (1997). N Engl J Med 337 ...
